SIGA Technologies Inc
$ 6.76
0.75%
24 Feb - close price
- Market Cap 480,512,000 USD
- Current Price $ 6.76
- High / Low $ 6.91 / 6.73
- Stock P/E 6.51
- Book Value 2.84
- EPS 1.03
- Next Earning Report 2026-03-10
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.26 %
- ROE 0.40 %
- 52 Week High 9.62
- 52 Week Low 4.48
About
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health safety and infectious disease markets in the United States. The company is headquartered in New York, New York.
Analyst Target Price
$17.53
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-05 | 2025-05-05 | 2025-03-10 | 2024-11-07 | 2024-08-01 | 2024-05-07 | 2024-03-12 | 2023-11-07 | 2023-08-08 | 2023-05-04 | 2023-03-02 |
| Reported EPS | -0.0889 | 0.49 | -0.0057 | 0.6409 | 0.0187 | 0.0255 | 0.1436 | 1.0164 | -0.01 | -0.04 | -0.01 | -0.01 |
| Estimated EPS | 0 | 0 | None | None | None | None | 0.14 | 1.01 | -0.01 | -0.04 | -0.01 | -0.01 |
| Surprise | -0.0889 | 0.49 | 0 | 0 | 0 | 0 | 0.0036 | 0.0064 | 0 | 0 | 0 | 0 |
| Surprise Percentage | None% | None% | None% | None% | None% | None% | 2.5714% | 0.6337% | 0% | 0% | 0% | 0% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-10 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | |
| Currency | USD |
Previous Dividend Records
| May 2025 | Apr 2024 | Jun 2023 | Jun 2022 | |
|---|---|---|---|---|
| Payment Date | 2025-05-15 | 2024-04-11 | 2023-06-01 | 2022-06-02 |
| Amount | $0.6 | $0.6 | $0.45 | $0.45 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SIGA
2026-02-18 03:24:00
This article provides an AI-driven analysis of Siga Technologies Inc. (NASDAQ: SIGA), highlighting strong near-term sentiment with a long-term positive bias. It details three trading strategies—Position, Momentum Breakout, and Risk Hedging—along with specific entry, target, and stop-loss zones. The analysis also includes multi-timeframe signal insights and offers access to real-time signals and personalized alerts.
2026-02-13 11:32:00
SIGA Technologies Inc. specializes in antiviral treatments, with TPOXX for smallpox as its flagship product, operating in the health security market. Despite a significant revenue growth decline of 73.80%, the company boasts a strong return on equity of 39.94% and considerable free cash flow. While there's an absence of analyst coverage, SIGA's strategic market position and innovative products present a unique opportunity for investors willing to conduct their own due diligence.
2026-02-07 02:16:00
This report provides a price-driven analysis for Siga Technologies Inc. (NASDAQ: SIGA), indicating a neutral near and mid-term sentiment but a positive long-term bias. It outlines three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with support and resistance levels across different time horizons. The analysis highlights an exceptional risk-reward setup with a potential 21.1% gain.
2026-02-05 21:01:15
Stock traders recently bought an unusually large volume of call options on Siga Technologies (NASDAQ:SIGA), with 1,200 calls purchased, representing a 1,438% increase over its average daily volume. The company, a specialty pharmaceutical firm known for its antiviral TPOXX, trades near $6.73, has a market cap of $482 million, and recently reported a quarterly EPS loss. Despite institutional investors owning 55.4% of shares, analysts currently rate the stock as "Sell."
2026-01-27 01:08:00
Siga Technologies Inc. (NASDAQ: SIGA) shows strong sentiment across all horizons, leading to an overweight bias. The article details an exceptional 66.5:1 risk-reward setup targeting a 20.8% gain, with current signals highlighting a mid-channel oscillation pattern. Three distinct AI-generated trading strategies are provided, catering to different risk profiles and holding periods, alongside a multi-timeframe signal analysis.
2026-01-21 22:03:00
SIGA Technologies recently disclosed $80,000 in lobbying expenditures for Q4 2025, focusing on "Biodefense funding." This update also highlights significant hedge fund activity, with some institutional investors increasing their holdings in SIGA stock while others reduced their positions.
